Agresta Samuel
SEC CIK 1748961 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | Chief Medical Off | 311.3K | — | $2.57M | 2 | 2023-08-16 | 2023-08-16 |
Most active insiders at FHTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOTTSCHALK ADRIAN | CEO, Dir | — | — |
Agresta Samuel made no open-market trades at FHTX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-18 | 2023-08-16 | FHTX | Foghorn Therapeutics Inc. | Agresta Samuel | Chief Medical Off | M - OptEx | $3.72 | +311.3K | 311.3K | New | +$1.16M |
| D | 2023-08-18 | 2023-08-16 | FHTX | Foghorn Therapeutics Inc. | Agresta Samuel | Chief Medical Off | S - Sale+OE | $8.25 | -311.3K | 0 | -100% | -$2.57M |
Purchase Sale Sale after option exercise All abbreviations